HK1253945A1 - 麥芽糖依賴性降解決定子、麥芽糖響應型啟動子、穩定化構建體及其在生成非分解代謝化合物中的用途 - Google Patents
麥芽糖依賴性降解決定子、麥芽糖響應型啟動子、穩定化構建體及其在生成非分解代謝化合物中的用途Info
- Publication number
- HK1253945A1 HK1253945A1 HK18113095.7A HK18113095A HK1253945A1 HK 1253945 A1 HK1253945 A1 HK 1253945A1 HK 18113095 A HK18113095 A HK 18113095A HK 1253945 A1 HK1253945 A1 HK 1253945A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- maltose
- production
- responsive promoters
- catabolic compounds
- dependent degrons
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/635—Externally inducible repressor mediated regulation of gene expression, e.g. tetR inducible by tetracyline
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/65—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
- C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
- C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P5/00—Preparation of hydrocarbons or halogenated hydrocarbons
- C12P5/02—Preparation of hydrocarbons or halogenated hydrocarbons acyclic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P5/00—Preparation of hydrocarbons or halogenated hydrocarbons
- C12P5/02—Preparation of hydrocarbons or halogenated hydrocarbons acyclic
- C12P5/026—Unsaturated compounds, i.e. alkenes, alkynes or allenes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
- C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
- C07K14/395—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Saccharomyces
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/24—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a MBP (maltose binding protein)-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/95—Fusion polypeptide containing a motif/fusion for degradation (ubiquitin fusions, PEST sequence)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2330/00—Production
- C12N2330/50—Biochemical production, i.e. in a transformed host cell
- C12N2330/51—Specially adapted vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y503/00—Intramolecular oxidoreductases (5.3)
- C12Y503/03—Intramolecular oxidoreductases (5.3) transposing C=C bonds (5.3.3)
- C12Y503/03002—Isopentenyl-diphosphate DELTA-isomerase (5.3.3.2)
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Botany (AREA)
- Gastroenterology & Hepatology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562184793P | 2015-06-25 | 2015-06-25 | |
US201562266436P | 2015-12-11 | 2015-12-11 | |
PCT/US2016/039386 WO2016210343A1 (en) | 2015-06-25 | 2016-06-24 | Maltose dependent degrons, maltose-responsive promoters, stabilization constructs, and their use in production of non-catabolic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1253945A1 true HK1253945A1 (zh) | 2019-07-05 |
Family
ID=56345272
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18113095.7A HK1253945A1 (zh) | 2015-06-25 | 2018-10-12 | 麥芽糖依賴性降解決定子、麥芽糖響應型啟動子、穩定化構建體及其在生成非分解代謝化合物中的用途 |
HK18113115.3A HK1254052A1 (zh) | 2015-06-25 | 2018-10-12 | 麥芽糖依賴性降解決定子、麥芽糖響應型啟動子、穩定化構建體及其在生成非分解代謝化合物中的用途 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18113115.3A HK1254052A1 (zh) | 2015-06-25 | 2018-10-12 | 麥芽糖依賴性降解決定子、麥芽糖響應型啟動子、穩定化構建體及其在生成非分解代謝化合物中的用途 |
Country Status (7)
Country | Link |
---|---|
US (4) | US10808015B2 (zh) |
EP (2) | EP3313996A1 (zh) |
CN (2) | CN108474008A (zh) |
AU (2) | AU2016284696B2 (zh) |
BR (2) | BR112017027869A2 (zh) |
HK (2) | HK1253945A1 (zh) |
WO (2) | WO2016210343A1 (zh) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3663392A1 (en) * | 2013-08-07 | 2020-06-10 | Amyris, Inc. | Methods for stabilizing production of acetyl-coenzyme a derived compounds |
CN108474008A (zh) | 2015-06-25 | 2018-08-31 | 阿迈瑞斯公司 | 麦芽糖依赖性降解决定子、麦芽糖响应型启动子、稳定化构建体及其在生成非分解代谢化合物中的用途 |
US11446398B2 (en) | 2016-04-11 | 2022-09-20 | Obsidian Therapeutics, Inc. | Regulated biocircuit systems |
PT3574105T (pt) | 2017-01-25 | 2021-05-31 | Amyris Bio Products Portugal Unipessoal Lda | Coprodução de um sesquiterpeno e um carotenoide |
US11629340B2 (en) | 2017-03-03 | 2023-04-18 | Obsidian Therapeutics, Inc. | DHFR tunable protein regulation |
EP3381932A1 (en) | 2017-03-28 | 2018-10-03 | Technische Universität Berlin | Modified mussel proteins, uses thereof and related compounds |
EP3720944A1 (en) | 2017-12-07 | 2020-10-14 | Zymergen Inc. | Engineered biosynthetic pathways for production of (6e)-8-hydroxygeraniol by fermentation |
CN111868047A (zh) | 2017-12-21 | 2020-10-30 | 齐默尔根公司 | 荆芥内半缩醛氧化还原酶、荆芥内半缩醛合酶和能够产生荆芥内酯的微生物 |
WO2019241315A1 (en) | 2018-06-12 | 2019-12-19 | Obsidian Therapeutics, Inc. | Pde5 derived regulatory constructs and methods of use in immunotherapy |
US20210386788A1 (en) | 2018-10-24 | 2021-12-16 | Obsidian Therapeutics, Inc. | Er tunable protein regulation |
US10519475B1 (en) | 2018-11-21 | 2019-12-31 | Amyris, Inc. | Biosynthesis of compounds in yeast |
CN110592131B (zh) * | 2018-12-14 | 2021-10-22 | 中国科学院天津工业生物技术研究所 | 麦芽糖转录激活因子MalR的突变体文库构建筛选及其应用 |
CN110592080B (zh) * | 2018-12-17 | 2021-11-23 | 中国科学院天津工业生物技术研究所 | 优化的麦芽糖启动子突变体及其应用 |
WO2020185632A1 (en) | 2019-03-08 | 2020-09-17 | Obsidian Therapeutics, Inc. | Human carbonic anhydrase 2 compositions and methods for tunable regulation |
US20220127620A1 (en) | 2019-03-15 | 2022-04-28 | Andrew P. Klein | Microbial production of compounds |
EP3983538A1 (en) | 2019-06-12 | 2022-04-20 | Obsidian Therapeutics, Inc. | Ca2 compositions and methods for tunable regulation |
WO2020252404A1 (en) | 2019-06-12 | 2020-12-17 | Obsidian Therapeutics, Inc. | Ca2 compositions and methods for tunable regulation |
CN114302958A (zh) * | 2019-06-24 | 2022-04-08 | 丹尼斯科美国公司 | 用于增加发酵联产物中赖氨酸含量的经修饰的酵母和方法 |
US20220282226A1 (en) | 2019-08-01 | 2022-09-08 | Amyris, Inc. | Modified host cells for high efficiency production of vanillin |
US20220348937A1 (en) | 2019-09-06 | 2022-11-03 | Obsidian Therapeutics, Inc. | Compositions and methods for dhfr tunable protein regulation |
CN110878288B (zh) * | 2019-12-09 | 2020-12-29 | 安徽农业大学 | 多肽、核酸及其在合成橙花叔醇糖苷上的应用 |
BR112023003204A2 (pt) | 2020-09-15 | 2023-03-28 | Amyris Inc | Composições de cultura e métodos de seu uso para produção de alto rendimento de vanilina |
EP4308713A1 (en) | 2021-03-19 | 2024-01-24 | Amyris, Inc. | Modified host cells for high efficiency production of vanillin |
WO2023230411A1 (en) | 2022-05-26 | 2023-11-30 | Amyris, Inc. | Improved oligosaccharide production in yeast |
WO2024064888A2 (en) * | 2022-09-23 | 2024-03-28 | North Carolina State University | Engineered microorganisms with enhanced protein expression and secretion |
CN115813869A (zh) * | 2022-12-15 | 2023-03-21 | 深圳市奥极因科技有限公司 | 一种感知进食状态智能给药的重组菌含片 |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3477936D1 (en) | 1983-03-08 | 1989-06-01 | Merck & Co Inc | Recombinant dna cloning vector pve1, deletion and hybrid mutants, and recombinant derivatives thereof, products and processes |
US4703009A (en) | 1983-03-08 | 1987-10-27 | Merck & Co., Inc. | RDNA cloning vector pVE1, deletion and hybrid mutants and recombinant derivatives thereof products and processes |
US5272065A (en) | 1983-10-20 | 1993-12-21 | Research Foundation Of State University Of New York | Regulation of gene expression by employing translational inhibition of MRNA utilizing interfering complementary MRNA |
US5672497A (en) | 1986-03-21 | 1997-09-30 | Eli Lilly And Company | Method for increasing the antibiotic-producing ability of antibiotic-producing microorganisms |
CA1340599C (en) | 1986-03-21 | 1999-06-22 | Karen Leigh Cox | Antibiotic-producing microorganisms |
US5098837A (en) | 1988-06-07 | 1992-03-24 | Eli Lilly And Company | Macrolide biosynthetic genes for use in streptomyces and other organisms |
US5149638A (en) | 1988-09-29 | 1992-09-22 | Eli Lilly And Company | Tylosin biosynthetic genes tylA, tylB and tylI |
US5252474A (en) | 1989-03-31 | 1993-10-12 | Merck & Co., Inc. | Cloning genes from Streptomyces avermitilis for avermectin biosynthesis and the methods for their use |
WO1993013663A1 (en) | 1992-01-17 | 1993-07-22 | Abbott Laboratories | Method of directing biosynthesis of specific polyketides |
US5824513A (en) | 1991-01-17 | 1998-10-20 | Abbott Laboratories | Recombinant DNA method for producing erythromycin analogs |
US6060234A (en) | 1991-01-17 | 2000-05-09 | Abbott Laboratories | Polyketide derivatives and recombinant methods for making same |
EP0726940A4 (en) | 1993-11-02 | 2001-05-23 | Merck & Co Inc | DNA ENCODING A TRIOL-POLYCETIDE-SYNTHASE |
US5716849A (en) | 1994-06-08 | 1998-02-10 | Novartis Finance Corporation | Genes for the biosynthesis of soraphen |
US5824545A (en) | 1995-11-01 | 1998-10-20 | Millennium Pharaceuticals, Inc. | Identification of eukaryotic growth-related genes and promoter isolation vector and method of use |
CA2197160C (en) | 1996-02-22 | 2007-05-01 | Stanley Gene Burgett | Platenolide synthase gene |
CA2197524A1 (en) | 1996-02-22 | 1997-08-22 | Bradley Stuart Dehoff | Polyketide synthase genes |
WO1998007868A1 (en) | 1996-08-20 | 1998-02-26 | Novartis Ag | Rifamycin biosynthesis gene cluster |
WO1999005283A2 (fr) | 1997-07-25 | 1999-02-04 | Hoechst Marion Roussel | Genes de biosynthese et de transfert des 6-desoxyhexoses chez saccharopolyspora erythraea et chez streptomyces antibioticus et leur utilisation |
US6090601A (en) | 1998-01-23 | 2000-07-18 | Kosan Bioscience | Sorangium polyketide synthase |
US6143526A (en) | 1998-03-09 | 2000-11-07 | Baltz; Richard H. | Biosynthetic genes for spinosyn insecticide production |
CA2328427A1 (en) | 1998-05-28 | 1999-12-02 | Kosan Biosciences, Inc. | Recombinant narbonolide polyketide synthase |
NZ508326A (en) | 1998-06-18 | 2003-10-31 | Novartis Ag | A polyketide synthase and non ribosomal peptide synthase genes, isolated from a myxobacterium, necessary for synthesis of epothiones A and B |
US6265202B1 (en) | 1998-06-26 | 2001-07-24 | Regents Of The University Of Minnesota | DNA encoding methymycin and pikromycin |
IL142165A0 (en) | 1998-10-02 | 2002-03-10 | Kosan Biosciences Inc | Polyketide synthase enzymes and recombinant dna constructs therefor |
JP2003512013A (ja) | 1998-10-29 | 2003-04-02 | コーサン バイオサイエンシーズ, インコーポレイテッド | 組換えオレアンドライドポリケチドシンターゼ |
AU768220B2 (en) | 1998-11-20 | 2003-12-04 | Kosan Biosciences, Inc. | Recombinant methods and materials for producing epothilone and epothilone derivatives |
AU7332301A (en) * | 2000-07-19 | 2002-02-05 | Advanced Res & Tech Inst | Novel fibroblast growth factor (FGF23) and methods for use |
EP1379549A2 (fr) * | 2001-02-07 | 2004-01-14 | Institut Pasteur | Sequence du genome de photorhabdus luminescens souche tto1 et utilisations |
US7192751B2 (en) | 2001-12-06 | 2007-03-20 | The Regents Of The University Of California | Biosynthesis of amorpha-4,11-diene |
GB0402660D0 (en) * | 2004-02-06 | 2004-03-10 | Medical Res Council | Heterologous protein expression |
US20060141570A1 (en) * | 2004-11-16 | 2006-06-29 | Wood David W | Intein-mediated protein purification using in vivo expression of an aggregator protein |
CN101443354A (zh) * | 2006-04-14 | 2009-05-27 | 新英格兰生物实验室公司 | 与突变麦芽糖结合蛋白融合的靶蛋白的溶解和纯化 |
US8623615B2 (en) * | 2009-04-01 | 2014-01-07 | New England Biolabs, Inc. | Solubilization and purification of a target protein fused to a mutant maltose-binding protein |
JP6158170B2 (ja) | 2011-04-27 | 2017-07-12 | アミリス, インコーポレイテッド | ゲノム修飾のための方法 |
CA2879178C (en) * | 2012-08-07 | 2020-11-24 | Amyris, Inc. | Methods for stabilizing production of acetyl-coenzyme a derived compounds |
EP3663392A1 (en) | 2013-08-07 | 2020-06-10 | Amyris, Inc. | Methods for stabilizing production of acetyl-coenzyme a derived compounds |
CN108474008A (zh) * | 2015-06-25 | 2018-08-31 | 阿迈瑞斯公司 | 麦芽糖依赖性降解决定子、麦芽糖响应型启动子、稳定化构建体及其在生成非分解代谢化合物中的用途 |
-
2016
- 2016-06-24 CN CN201680048933.5A patent/CN108474008A/zh active Pending
- 2016-06-24 BR BR112017027869-3A patent/BR112017027869A2/pt active Search and Examination
- 2016-06-24 CN CN201680048935.4A patent/CN108474009B/zh active Active
- 2016-06-24 AU AU2016284696A patent/AU2016284696B2/en active Active
- 2016-06-24 EP EP16739303.2A patent/EP3313996A1/en active Pending
- 2016-06-24 BR BR112017027970-3A patent/BR112017027970A2/pt active Search and Examination
- 2016-06-24 WO PCT/US2016/039386 patent/WO2016210343A1/en active Application Filing
- 2016-06-24 AU AU2016284689A patent/AU2016284689B9/en active Active
- 2016-06-24 WO PCT/US2016/039397 patent/WO2016210350A1/en active Application Filing
- 2016-06-24 US US15/738,555 patent/US10808015B2/en active Active
- 2016-06-24 EP EP16734852.3A patent/EP3313995B9/en active Active
- 2016-06-24 US US15/738,918 patent/US10988513B2/en active Active
-
2018
- 2018-10-12 HK HK18113095.7A patent/HK1253945A1/zh unknown
- 2018-10-12 HK HK18113115.3A patent/HK1254052A1/zh unknown
-
2020
- 2020-09-04 US US17/013,246 patent/US20200399326A1/en active Pending
-
2021
- 2021-04-02 US US17/221,371 patent/US20210230234A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP3313995B9 (en) | 2023-10-04 |
AU2016284689A1 (en) | 2018-01-25 |
US20210230234A1 (en) | 2021-07-29 |
AU2016284696A1 (en) | 2018-01-25 |
EP3313995B1 (en) | 2023-06-07 |
US20180171341A1 (en) | 2018-06-21 |
AU2016284689B9 (en) | 2022-01-20 |
AU2016284696B2 (en) | 2021-10-28 |
US10808015B2 (en) | 2020-10-20 |
US20200399326A1 (en) | 2020-12-24 |
US20180186841A1 (en) | 2018-07-05 |
US10988513B2 (en) | 2021-04-27 |
HK1254052A1 (zh) | 2019-07-12 |
BR112017027970A2 (pt) | 2018-08-28 |
EP3313995A1 (en) | 2018-05-02 |
EP3313996A1 (en) | 2018-05-02 |
EP3313995C0 (en) | 2023-06-07 |
CN108474009A (zh) | 2018-08-31 |
WO2016210343A1 (en) | 2016-12-29 |
BR112017027869A2 (pt) | 2018-09-11 |
CN108474008A (zh) | 2018-08-31 |
CN108474009B (zh) | 2022-10-04 |
WO2016210350A1 (en) | 2016-12-29 |
AU2016284689B2 (en) | 2021-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1254052A1 (zh) | 麥芽糖依賴性降解決定子、麥芽糖響應型啟動子、穩定化構建體及其在生成非分解代謝化合物中的用途 | |
IL259367B (en) | Promoters and their uses | |
HK1232140A1 (zh) | 微類器官以及製造和使用它們的方法 | |
SG10201912671YA (en) | Structured adsorbent beds, methods of producing the same and uses thereof | |
ZA201701837B (en) | Stable fungal blastospores and methods for their production, stabilization and use | |
IL246987A0 (en) | Heteroaryl amides, preparations containing it and their uses | |
EP3320008C0 (en) | NOVEL URETHANE-BASED MATERIALS, DERIVATIVES, THEIR PREPARATION PROCESSES AND THEIR USES | |
IL287825A (en) | Structures of sirp-alpha variant and their uses | |
IL251827B (en) | kcnq2-5 channel activators, preparations containing them and their uses | |
PL3572405T3 (pl) | Amidy benzoimidazol-1,2-ylowe jako aktywatory kanału kv7 | |
PL3133153T3 (pl) | Nowy bakteriofag i zawierająca go kompozycja | |
HK1244842A1 (zh) | 截短的普魯蘭酶及其生產方法和使用方法 | |
SG11201803581VA (en) | Chimeric RSV, Immunogenic Compositions, and Methods of Use | |
PL3133151T3 (pl) | Nowy bakteriofag i zawierająca go kompozycja | |
PL2998311T3 (pl) | Mieszanina alkiloglikozydów, ich wytwarzanie i zastosowanie | |
SG11201609066QA (en) | Methods of producing tissue-mimetic constructs and uses thereof | |
GB201721204D0 (en) | Novel form of isoxadifen-ethyl, process for preparation and use thereof | |
IL264165A (en) | Inhibited starches, coagulation retarders and methods of using them | |
PL3135761T3 (pl) | Nowy bakteriofag i zawierająca go kompozycja | |
PL3386988T3 (pl) | Nowe pochodne dihydropiranopirymidynonu i ich zastosowanie | |
HUE048394T2 (hu) | Új triazolopirimidinon vagy triazolopyridinone származékok és ezek felhasználása | |
GB201615010D0 (en) | Delayed-gelling, inhibited starches and methods of using them | |
GB201501474D0 (en) | Agent, product and use | |
GB201407975D0 (en) | Stabilization of the spine | |
AU2014903480A0 (en) | Nacre-like composites, methods of synthesis and methods of use |